Large Differences between Focal and Diffuse Patterns of Stable CAD

PCI is far more successful at reducing ischemia when treating focal stable coronary artery disease (CAD). However, there were no differences in symptoms between both types of CAD. 

Grandes diferencias entre angioplastia en enfermedad focal vs difusa

Physiological assessment with pressure wire pullback can be used to distinguish focal vs diffuse CAD, even though the relevance of this distinction has not been looked at closely. 

Using the ORBITA database, researchers tested PCI efficacy against placebo in both types of CAD patterns (focal vs diffuse). They observed the impact of these patterns on stress echocardiography ischemia and symptom end points. 

164 patients were assessed with iFR pullback before randomization. Focal CAD was defined as iFR drop >0.03 within 15 mm. Greater distances were defined as diffuse CAD. 

Of the 85 patients in the ORBITA PCI branch, 48 showed focal lesions and 37 diffuse CAD. IN the placebo arm (n=79) 35 had focal lesions and 44 diffuse CAD.

Focal stenosis was associated with significantly lower FFR and iFR vs. diffuse pattern patients (mean FFR and iFR, focal 0.60±0.15 and 0.65±0.24, diffuse 0.78±0.10 and 0.88±0.08, respectively, p<0.0001).


Read also: New Markers of Aortic Stenosis Define Asymptomatic Patients.


Stress echocardiography ischemia saw significantly greater reduction with PCI when patients showed a focal pattern, vs. a diffuse pattern (p<0.05). 

PCI did not show significant variation in exercise time pre and post randomization. This continued to be true after stratifying patients according to CAD pattern. 

PCI was superior to placebo when using the Seattle Angina Questionnaire both in frequency and freedom from symptoms. However, these differences continued to be true and similar when stratifying patients into focal and diffuse CAD. 

Conclusion

PCI achieve greater ischemia reduction with focal CAD vs. diffuse. There were no differences in symptom end points. 

CIRCINTERVENTIONS-120-009891

Original Title: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease.

Reference: Christopher A Rajkumar et al. Circ Cardiovasc Interv. 2021 Aug 3;CIRCINTERVENTIONS120009891. Online ahead of print. doi: 10.1161/CIRCINTERVENTIONS.120.009891.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...